Integrating multi-omics data revealing LIMK1 as a metastatic biomarker in LUAD patients with brain metastasis
Abstract Background Lung adenocarcinoma (LUAD) is a major subtype of lung cancer that frequently develops brain metastases. Tumor heterogeneity substantially complicates disease management, and reliable biomarkers for metastatic progression remain lacking. LIM domain kinase 1 (LIMK1), a key regulato...
Guardat en:
| Autors principals: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2026-03-01
|
| Col·lecció: | Cancer Cell International |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s12935-026-04278-3 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|